Germany approves trials of COVID-19 vaccine candidate

Germany approves trials of COVID-19 vaccine candidate

By Excelsio Media on April 23, 2020 Also in covid-19, Germany, health

Germany has given the green light for human trials of potential coronavirus vaccines developed by German biotech company BioNTech, which is racing teams in Germany, the U.S. and China to develop an agent that will stop the pandemic.

Comments

Comentarios de Facebook

Subscribe to: Post Comments (Atom)